ACGT Blog.
ACGT hosts lunch symposium, SAC members honored at SITC 2025.
ACGT had a strong presence at this year’s SITC 2025 Annual Meeting in National Harbor, Maryland, hosting a Lunch Symposium that brought together leading experts in cancer cell and gene therapy to connect and share knowledge and insights.
Read More
ACGT hosts lunch symposium, SAC members honored at SITC 2025.
ACGT had a strong presence at this year’s SITC 2025 Annual Meeting in National Harbor, Maryland, hosting a Lunch Symposium that brought together leading experts in cancer cell and gene therapy to connect and share knowledge and insights.
Read More
19th annual SAA-FC open water swim raises more than $400K for ACGT
Close to 230 swimmers hit the water on June 21 in Stamford, Conn., for the annual Swim Across America – Fairfield County open water swim, which benefited ACGT for the 19th consecutive year.
Read More
19th annual SAA-FC open water swim raises more than $400K for ACGT
Close to 230 swimmers hit the water on June 21 in Stamford, Conn., for the annual Swim Across America – Fairfield County open water swim, which benefited ACGT for the 19th consecutive year.
Read More
FDA convenes roundtable on cell and gene therapy.
On June 5th, FDA held a cell and gene therapy roundtable discussing rare disease and cancer therapies and the opportunity to consider product development from the patient and family point of view. Leading experts, including ACGT Scientific Advisory Council members and Research Fellows Dr Crystal Mackall and Dr Carl June, were invited to share with FDA the progress and challenges and, most importantly, the incredible potential in curing diseases through cell and gene therapies.
Read More
FDA convenes roundtable on cell and gene therapy.
On June 5th, FDA held a cell and gene therapy roundtable discussing rare disease and cancer therapies and the opportunity to consider product development from the patient and family point of view. Leading experts, including ACGT Scientific Advisory Council members and Research Fellows Dr Crystal Mackall and Dr Carl June, were invited to share with FDA the progress and challenges and, most importantly, the incredible potential in curing diseases through cell and gene therapies.
Read More
